D.O. Morgan

1.5k total citations
35 papers, 1.2k citations indexed

About

D.O. Morgan is a scholar working on Cardiology and Cardiovascular Medicine, Agronomy and Crop Science and Molecular Biology. According to data from OpenAlex, D.O. Morgan has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 25 papers in Agronomy and Crop Science and 20 papers in Molecular Biology. Recurrent topics in D.O. Morgan's work include Viral Infections and Immunology Research (25 papers), Animal Disease Management and Epidemiology (25 papers) and Viral Infectious Diseases and Gene Expression in Insects (17 papers). D.O. Morgan is often cited by papers focused on Viral Infections and Immunology Research (25 papers), Animal Disease Management and Epidemiology (25 papers) and Viral Infectious Diseases and Gene Expression in Insects (17 papers). D.O. Morgan collaborates with scholars based in United States, United Kingdom and Spain. D.O. Morgan's co-authors include James G. Lecce, Barry Baxt, Marvin J. Grubman, D. M. Moore, Betty H. Robertson, G. Matrone, Vikram N. Vakharia, Samuel A. Lewis, J.W. Stave and Bernard Rees Smith and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and FEBS Letters.

In The Last Decade

D.O. Morgan

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.O. Morgan United States 20 807 754 425 325 149 35 1.2k
Lucie Lamontagne Canada 18 143 0.2× 75 0.1× 205 0.5× 79 0.2× 360 2.4× 58 1.1k
L. Kirk Clark United States 20 212 0.3× 29 0.0× 102 0.2× 98 0.3× 296 2.0× 55 939
Ming‐Chung Deng Taiwan 16 442 0.5× 338 0.4× 108 0.3× 187 0.6× 277 1.9× 36 746
Shuangqi Fan China 19 425 0.5× 233 0.3× 262 0.6× 219 0.7× 196 1.3× 56 939
Jin‐Ju Nah South Korea 17 259 0.3× 135 0.2× 318 0.7× 202 0.6× 81 0.5× 49 886
Bart Mateusen Belgium 17 381 0.5× 41 0.1× 262 0.6× 16 0.0× 244 1.6× 38 1.2k
Miriam Pedrera Spain 19 419 0.5× 68 0.1× 100 0.2× 309 1.0× 196 1.3× 51 796
Ruby J. Larson United States 10 730 0.9× 268 0.4× 206 0.5× 329 1.0× 200 1.3× 10 962
Y Kawakami Japan 18 172 0.2× 21 0.0× 141 0.3× 214 0.7× 59 0.4× 56 825
J.F. Żmudziński Poland 14 328 0.4× 49 0.1× 153 0.4× 307 0.9× 43 0.3× 95 883

Countries citing papers authored by D.O. Morgan

Since Specialization
Citations

This map shows the geographic impact of D.O. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.O. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.O. Morgan more than expected).

Fields of papers citing papers by D.O. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.O. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.O. Morgan. The network helps show where D.O. Morgan may publish in the future.

Co-authorship network of co-authors of D.O. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of D.O. Morgan. A scholar is included among the top collaborators of D.O. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.O. Morgan. D.O. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrillo, C., D. M. Moore, Francisco Sobrino, Manuel V. Borca, & D.O. Morgan. (1998). In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies.. Journal of General Virology. 79(7). 1699–1706. 28 indexed citations
2.
Butchaiah, G. & D.O. Morgan. (1997). Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants. Virus Research. 52(2). 183–194. 13 indexed citations
3.
Smitsaart, Eliana, Elias J. Fernandez, Eduardo Maradei, & D.O. Morgan. (1994). Validation of an Inhibition ELISA using a Monoclonal Antibody for Foot‐and‐Mouth Disease (FMD) Primary Diagnosis. Journal of Veterinary Medicine Series B. 41(1-10). 313–319. 2 indexed citations
4.
Borca, Manuel V., Antonio E. Garmendia, Barry Baxt, et al.. (1993). Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.. PubMed. 79(3). 368–74. 4 indexed citations
5.
Butchaiah, G., et al.. (1992). Antigenic relationships of foot-and-mouth disease virus serotype Asia-1 isolates demonstrated by monoclonal antibodies. Veterinary Immunology and Immunopathology. 30(2-3). 275–292. 8 indexed citations
6.
Borca, Manuel V., et al.. (1990). Antibodies Elicited by a Biosynthetic Peptide Related to a Major Immunogenic Area of FMDV A12. Viral Immunology. 3(2). 147–160. 3 indexed citations
7.
Baxt, Barry, Antonio E. Garmendia, & D.O. Morgan. (1989). Characterization of Anti-idiotypic Antibodies Generated Against Foot-and-Mouth Disease Virus Neutralizing Monoclonal Antibodies. Viral Immunology. 2(2). 103–113. 13 indexed citations
8.
McCahon, D., J. R. Crowther, Graham J. Belsham, et al.. (1989). Evidence for At Least Four Antigenic Sites on Type O Foot-and-Mouth Disease Virus Involved in Neutralization; Identification by Single and Multiple Site Monoclonal Antibody-resistant Mutants. Journal of General Virology. 70(3). 639–645. 80 indexed citations
9.
10.
Baxt, Barry, et al.. (1989). Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. Journal of Virology. 63(5). 2143–2151. 141 indexed citations
11.
12.
Grubman, Marvin J., et al.. (1985). Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. Journal of Virology. 56(1). 120–126. 60 indexed citations
13.
Phillips, David I. W., et al.. (1985). THE GEOGRAPHICAL DISTRIBUTION OF THYROTOXICOSIS IN ENGLAND ACCORDING TO THE PRESENCE OR ABSENCE OF TSH‐RECEPTOR ANTIBODIES. Clinical Endocrinology. 23(3). 283–287. 40 indexed citations
14.
Robertson, Betty H., D.O. Morgan, & D. M. Moore. (1984). Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Research. 1(6). 489–500. 38 indexed citations
15.
Grubman, Marvin J., Betty H. Robertson, D.O. Morgan, D. M. Moore, & Donald Dowbenko. (1984). Biochemical map of polypeptides specified by foot-and-mouth disease virus. Journal of Virology. 50(2). 579–586. 51 indexed citations
16.
Baxt, Barry, et al.. (1984). Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. Journal of Virology. 51(2). 298–305. 88 indexed citations
17.
Morgan, D.O., Howard L. Bachrach, & P. D. McKercher. (1969). Immunogenicity of Nanogram to Milligram Quantities of Inactivated Foot-and-Mouth Disease Virus. I. Relative Virus-neutralizing Potency of Guinea Pig Sera. Applied Microbiology. 17(3). 441–445. 11 indexed citations
18.
Lecce, James G., D.O. Morgan, & G. Matrone. (1964). Effect of Feeding Colostral and Milk Components on the Cessation of Intestinal Absorption of Large Molecules (Closure) in Neonatal Pigs. Journal of Nutrition. 84(1). 43–48. 43 indexed citations
19.
Lecce, James G. & D.O. Morgan. (1962). Effect of Dietary Regimen on Cessation of Intestinal Absorption of Large Molecules (Closure) in the Neonatal Pig and Lamb. Journal of Nutrition. 78(3). 263–268. 119 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucie Lamontagne Breakdown of academic impact, for papers by L. Kirk Clark Breakdown of academic impact, for papers by Ming‐Chung Deng Breakdown of academic impact, for papers by Shuangqi Fan Breakdown of academic impact, for papers by Jin‐Ju Nah Breakdown of academic impact, for papers by Bart Mateusen Breakdown of academic impact, for papers by Miriam Pedrera Breakdown of academic impact, for papers by Ruby J. Larson Breakdown of academic impact, for papers by Y Kawakami Breakdown of academic impact, for papers by J.F. Żmudziński
Rankless by CCL
2026